| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide |
| Brand | Symtuza® |
| Indication | For the treatment of HIV-1 in adults and adolescents. |
| Assessment Process | |
| Rapid review commissioned | 27/09/2017 |
| Rapid review completed | 26/10/2017 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |